develop
earli
diagnost
reagent
effect
vaccin
even
drug
sarsassoci
coronaviru
sarscov
human
singl
fold
singlechain
antibodi
fragment
scfv
librari
j
tomlinson
j
use
identifi
novel
scfv
specif
bind
sarscov
interestingli
two
scfv
exhibit
higher
bind
specif
sarscov
od
valu
respect
code
sequenc
share
ident
sequenc
compos
v
h
gene
bp
v
l
gene
bp
two
scfv
uniformli
name
chosen
analysi
scfv
express
solubl
form
escherichia
coli
purifi
immobil
metal
affin
chromatographi
solubl
kda
scfvantibodi
verifi
sdspage
westernblot
purifi
scfvantibodi
label
hrp
glutaraldehyd
method
concentr
hrp
scfvantibodi
solut
reach
mgml
respect
bind
abil
sarscov
evalu
elisa
sn
indic
higher
bind
specif
final
sequenc
specif
applic
diagnosi
prophylaxi
therapi
sar
discuss
sever
acut
respiratori
syndrom
sar
signific
morbid
mortal
caus
sarscov
respons
first
pandem
centuri
caus
probabl
case
worldwid
death
howev
current
effect
vaccin
antivir
compound
prevent
cure
diseas
furthermor
current
reliabl
diagnost
test
diagnos
patient
monitor
spread
henc
singlechain
antibodi
fragment
specif
sarscov
phagedisplay
antibodi
librari
potenti
exploit
diagnost
even
antivir
therapeut
reagent
phage
display
vivo
select
techniqu
billion
peptid
protein
fuse
one
capsid
protein
express
nterminu
capsid
protein
pviii
piii
filament
bacteriophag
fd
display
surfac
phage
particl
two
signific
point
techniqu
one
provid
natur
linkag
phenotyp
genotyp
lie
fact
allow
specif
screen
base
bind
affin
given
target
molecular
vivo
select
process
call
pan
rapid
develop
matur
techniqu
often
effect
way
screen
protein
peptid
see
front
matter
elsevi
inc
right
reserv
import
applic
exampl
techniqu
use
antibodi
engin
peptid
protein
find
vaccin
manufactur
antibodi
engin
made
possibl
oper
gene
encod
antibodi
construct
antibodi
deriv
retain
entir
antigen
bind
function
deriv
includ
singlechain
antibodi
fragment
scfv
consist
variabl
region
heavi
light
chain
flexibl
linker
connect
function
scfvantibodi
express
singl
cdna
sequenc
enabl
gene
manipul
thu
manner
techniqu
great
potenti
basic
appli
research
work
research
group
util
techniqu
find
new
reagent
direct
sarscov
report
describ
use
synthet
phagemid
librari
gener
highaffin
scfv
antibodi
direct
new
coronaviru
affin
measur
plasmon
surfac
reson
specif
confirm
elisa
two
stronger
posit
scfv
design
sequenc
uniformli
design
homolog
chosen
express
purif
label
detect
research
furthermor
discuss
possibl
applic
scfvantibodi
diagnost
even
antivir
therapeut
reagent
librari
bacteria
reagent
human
singl
fold
scfv
librari
j
tomlinson
j
escherichia
coli
kindli
provid
mrc
geneservic
elisa
plate
coat
purifi
sarscov
lysat
posit
neg
sera
provid
militari
medic
scienc
academ
huada
gene
compani
beij
china
nbtbcip
sigma
polyhistidin
mous
antibodi
sigma
aplabel
antimous
antibodi
sabc
pharmacia
purchas
distributor
commonli
use
reagent
analyt
purif
grade
made
china
pan
assay
pan
procedur
perform
flexibl
assay
plate
coat
purifi
sarscov
lysat
block
directli
mpb
pb
contain
skim
milk
powder
room
temperatur
h
remov
block
solut
plate
wash
three
time
pb
primari
librari
solut
phage
mpb
ad
well
plate
stand
room
temperatur
h
unspecif
bind
phage
wash
away
pb
contain
tween
time
time
second
pan
time
third
pan
remain
phage
elut
ml
glycinehcl
buffer
ph
elut
fraction
subsequ
neutral
ml
trishcl
ph
parallel
ml
e
coli
cultur
ty
od
infect
elut
scfvphage
min
without
shake
small
proport
infect
e
coli
titrat
dilut
start
determin
scfvphage
titer
dilut
spot
separ
tye
plate
includ
lgml
ampicillin
glucos
cultur
overnight
titer
elut
scfvphage
calcul
clone
tye
plate
meanwhil
rest
infect
e
coli
spread
tye
plate
next
day
bacteria
plate
scrap
ad
ml
ty
lgml
ampicillin
glucos
amplif
procedur
phage
rescu
helper
phage
next
round
select
three
round
select
perform
prepar
scfvphage
last
select
round
individu
clone
randomli
pick
tye
plate
differ
well
ty
lgml
ampicillin
glucos
ad
advanc
flexibl
elisa
plate
cultur
small
inoculum
well
transfer
second
elisa
plate
contain
ty
lgml
ampicillin
glucos
per
well
origin
elisa
plate
store
temporarili
transfer
plate
shaken
h
phage
rescu
e
coli
ad
helper
phage
well
plate
shaken
h
spin
plate
min
supernat
thrown
away
pellet
suspend
ty
contain
lgml
ampicillin
lgml
kanamycin
cultur
rpm
overnight
overnight
cultur
spun
min
supernat
contain
scfvphage
use
monoclon
phage
elisa
monoclon
scfvphage
elisa
flexibl
elisa
plate
coat
sarscov
lysat
block
wash
describ
scfvphage
supernat
ad
well
plate
incub
h
room
temperatur
plate
wash
three
time
pb
contain
tween
subsequ
dilut
mpb
ad
well
incub
addit
h
well
wash
fresh
substrat
solut
lgml
mm
sodium
acet
ph
hydrogen
peroxid
ad
well
enzym
reaction
termin
ad
n
h
absorb
measur
nm
evalu
sn
sampleneg
dna
sequenc
two
stronger
posit
clone
monoclon
phage
elisa
sequenc
shanghai
casarray
gene
shanghai
china
two
sequenc
primer
use
forward
primer
cga
ccc
gcc
acc
gcc
gct
revers
primer
cta
tgc
ggc
ccc
att
express
westernblot
assay
select
scfvphage
inocul
e
coli
express
solubl
scfv
antibodi
briefli
e
coli
grown
ty
media
od
fifti
microlit
cultur
infect
scfvphage
singl
coloni
incub
min
without
shake
plate
tye
agar
lgml
ampicillin
singl
coloni
pick
plate
inocul
ml
ty
glucos
lgml
ampicillin
grown
overnight
shake
rpm
next
day
overnight
cultur
transfer
anoth
fresh
ty
glucos
lgml
ampicillin
grown
shake
rpm
od
iptg
ad
cultur
mm
final
concentr
shake
continu
rpm
one
millilit
cultur
aspir
h
ad
iptg
obtain
sampl
dispos
tradit
method
subject
electrophoresi
sdspage
whole
bacteria
protein
electrophoret
transfer
nitrocellulos
membran
gel
mm
tri
base
mm
glycin
methanol
v
h
membran
block
mpb
h
wash
pb
ml
antihistag
mous
antibodi
dilut
mpb
incub
membran
room
temperatur
h
bound
polyhistidin
mous
antibodi
detect
antimous
igg
alkalin
phosphatas
conjug
band
detect
addit
bcip
nbt
product
purif
scfvantibodi
order
acquir
larg
quantiti
purifi
scfvantibodi
overnight
activ
e
coli
infect
posit
scfvphage
cultur
transfer
ml
ty
glucos
lgml
ampicillin
mass
ratio
grown
rpm
express
scfvantibodi
induc
addit
iptg
mm
final
concentr
induct
h
cultur
cell
harvest
centrifug
min
wash
suspens
ml
pb
ph
centrifug
min
cell
pellet
store
use
cell
suspend
ml
pb
ph
contain
mm
edta
triton
sonic
centrifug
min
supernat
fluid
appli
column
cm
hisbond
ni
affin
resin
presenc
mm
sodium
phosphat
ph
mm
sodium
chlorid
mm
imidazol
extens
wash
ml
mm
sodium
phosphat
ph
mm
sodium
chlorid
mm
imidazol
bound
protein
elut
approxim
ml
mm
sodium
phosphat
ph
mm
sodium
chlorid
mm
imidazol
follow
extens
dialysi
pb
ph
puriti
protein
evalu
sdspage
protein
band
visual
coomassi
blue
stain
label
scfvantibodi
hrp
purifi
scfvantibodi
label
hrp
glutaraldehyd
method
elisa
elisa
use
measur
hrplabel
scfvantibodi
respons
sarscov
lysat
solut
titrat
dilut
start
determin
antibodi
titer
flexibl
elisa
plate
coat
sarscov
lysat
prepar
neg
control
three
well
coat
control
lysat
three
wash
pb
plate
block
mpb
well
empti
incub
h
conjug
variou
concentr
commerci
avail
sar
convalesc
serumhrp
conjug
use
control
well
wash
three
time
pb
incub
min
room
temperatur
substrat
solut
see
monoclon
scfvphage
elisa
fifti
microlit
sulfur
acid
ad
stop
reaction
absorb
measur
nm
statist
assay
student
test
use
statist
analysi
data
shown
mean
sd
signific
defin
p
human
synthet
scfv
librari
use
select
sarscovspecif
scfv
three
round
pan
done
flexibl
elisa
plate
coat
purifi
sarscov
lysat
round
pan
titer
elut
scfvphage
measur
monitor
effici
select
process
compar
second
round
number
scfvphage
elut
third
round
increas
indic
librari
alreadi
enrich
sarscovspecif
phage
fig
third
round
pan
clone
randomli
pick
assess
bind
sarscov
monoclon
scfvphage
elisa
result
fig
suggest
posit
clone
sn
also
show
higher
sarscovbind
specif
od
valu
sn
n
respect
chosen
analysi
complet
nucleotid
sequenc
heavi
light
chain
variabl
region
two
stronger
posit
clone
determin
result
indic
code
sequenc
share
ident
sequenc
fig
compos
v
h
gene
bp
v
l
gene
bp
two
scfv
uniformli
design
closest
germlin
sequenc
scfvantibodi
gene
could
identifi
comparison
databas
v
h
gene
use
v
h
familyderiv
germlin
j
h
gene
v
l
gene
use
v
l
vkappa
subgroup
v
k
familyderiv
germlin
j
k
gene
fig
also
high
degre
mutat
appear
v
h
cdr
complementaritydetermin
region
base
amino
acid
sequenc
homolog
closest
germlin
match
tabl
addit
replac
mutat
posit
fi
g
led
gener
stop
codon
tga
v
h
fwr
function
framework
region
could
surprisingli
suppress
scfvphage
express
e
coli
error
introduc
amplif
dna
exclud
sequenc
scfv
repeatedli
two
differ
compani
see
materi
method
obtain
result
deduc
amino
acid
sequenc
heavi
light
chain
shown
fig
predict
molecular
weight
whole
solubl
scfv
kda
express
solubl
scfvantibodi
identif
chosen
express
analysi
sampl
aspir
accord
induc
time
subject
sdspage
gel
western
blot
analysi
fig
perform
accord
former
describ
method
conclud
scfvantibodi
express
mw
kda
sinc
polyhistidin
tail
conform
westernblot
purif
result
scfvantibodi
shown
fig
purifi
scfvantibodi
migrat
singl
protein
band
sdspage
fig
estim
molecular
mass
kda
possess
high
degre
puriti
shown
fig
westernblot
analysi
purifi
scfvantibodi
also
verifi
result
sdspage
product
yield
purifi
scfvantibodi
around
mgl
product
cultur
valu
absorb
nm
puriti
solut
purifi
scfvantibodi
label
hrp
glutaraldehyd
method
concentr
hrp
scfvantibodi
solut
gl
respect
sdspage
result
solut
shown
fig
migrat
singl
protein
band
sdspage
estim
molecular
mass
kda
evid
bind
hrp
scfv
hrp
kda
scfvantibodi
kda
primarili
examin
effect
bind
sarscov
still
use
elisa
plate
coat
purifi
sarscov
lysat
solut
titrat
dilut
start
determin
antibodi
titer
data
shown
optim
dilut
degre
solut
ratio
chosen
elisa
tabl
analysi
nucleotid
amino
acid
sequenc
v
h
region
singlestrand
antibodi
gene
seen
tabl
comparison
posit
control
sar
convalesc
serumhrp
conjug
absorb
od
x
sd
test
reach
increas
howev
remark
signific
differ
level
observ
either
test
posit
control
neg
control
sn
respect
p
result
indic
also
bore
high
specif
sarscov
three
round
affin
select
obtain
eight
posit
scfv
specif
sarscov
interestingli
two
scfv
design
exhibit
higher
bind
specif
sarscov
od
valu
respect
code
sequenc
share
ident
sequenc
compos
v
h
gene
bp
v
l
gene
bp
moreov
comparison
closest
ig
germlin
v
gene
show
v
h
gene
deriv
v
h
famili
high
degre
mutat
appear
v
h
base
amino
acid
sequenc
homolog
closest
germlin
match
indic
v
h
scfvantibodi
gene
may
critic
region
specif
bind
scfv
sarscov
although
precis
mechan
action
unknown
studi
suggest
scfvantibodi
high
bind
specif
sarscov
elisa
sinc
react
well
sarscov
also
conceiv
might
restor
bind
properti
form
fusion
protein
express
solubl
scfv
e
coli
label
scfvhorseradish
peroxidas
describ
other
notabl
sdspage
result
solut
may
also
provid
evid
point
migrat
singl
protein
band
sdspage
estim
molecular
mass
kda
obvious
less
kda
total
molecular
weight
scfvantibodi
kda
hrp
kda
furthermor
creation
scfv
fuse
protein
believ
lead
format
dimer
greater
avid
stabil
origin
monoval
scfv
use
exampl
detect
purpos
present
laboratori
test
appli
routin
diagnosi
sar
mainli
includ
detect
viral
genom
pcr
involv
rtpcr
rtlamp
detect
serum
antibodi
use
sarscov
vero
cell
cultur
elisa
ifa
nt
howev
littl
progress
detect
sarscov
use
scfvantibodi
anticip
scfvantibodi
describ
use
detect
sarscov
addit
direct
sar
research
move
identifi
viru
sequenc
genom
analyz
viral
protein
role
viru
replic
pathogenesi
aim
develop
new
drug
vaccin
sar
fortun
progress
made
develop
new
drug
vaccin
sar
although
antivir
treatment
current
avail
sarscov
exampl
complet
inhibit
cytopath
effect
sarscov
cultur
observ
interferon
subtyp
human
leukocyt
interferon
vitro
efficaci
recombin
human
type
interferon
ifnb
serono
intern
geneva
switzerland
three
differ
isol
sarscov
urbani
use
yield
reduct
assay
evalu
threedimension
model
sarscovencod
cl
proteinas
construct
direct
design
proteas
inhibitor
may
block
coronaviru
replic
scfvantibodi
obtain
us
direct
purifi
sarscov
lysat
may
also
ideal
vaccin
candid
effect
molecul
guider
prophylaxi
therapi
summari
studi
demonstr
scfvantibodi
high
bind
specif
sarscov
elisa
potenti
applic
detect
reagent
vaccin
drug
sarscov
discuss
current
effort
underway
improv
sensit
elisa
assay
confirm
act
target
develop
clinic
applic
n
express
test
number
sn
absorb
od
ratio
sampl
neg
control
sign
indic
deviat
absorb
od
experiment
group
neg
control
dramat
signific
p
elisa
posit
defin
sn
